Aspire Biopharma Holdings Inc (ASBP)

Aug 20, 2025

Aspire Biopharma Holdings, Inc. Building a Base Near Support2025 Retail Activity & Weekly Setup with High ROI Potential - thegnnews.com

Aug 20, 2025

Aug 19, 2025

Aspire Biopharma Plummets 22.7%: E-Commerce Launch Volatility and Technical Divergence Spark Turbulence - AInvest

Aug 19, 2025

Aug 19, 2025

Aspire Biopharma Announces Positive Top-Line Results from Clinical Trial of Investigational New Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction (Heart Attack) - BioSpace

Aug 19, 2025

Aug 18, 2025

Penny Stocks on the Move: Today’s Top Gainers and Biggest Decliners - AInvest

Aug 18, 2025

Aug 18, 2025

Aspire Shares Are Trading Higher Monday: What's Going On? - Benzinga

Aug 18, 2025

Aug 18, 2025

Crude Oil Moves Higher; US Homebuilder Sentiment Declines In August - Benzinga

Aug 18, 2025

Aug 18, 2025

Aspire Biopharma Holdings shares surge 67.69% intraday after positive clinical trial results for sublingual aspirin product. - AInvest

Aug 18, 2025

Aug 18, 2025

US Stocks Mixed; Riskified Shares Dip After Q2 Results - Benzinga

Aug 18, 2025

Aug 18, 2025

Breakthrough Heart Attack Treatment: Sublingual Aspirin Shows Superior Results in Aspire Biopharma Trial - Stock Titan

Aug 18, 2025

Aug 18, 2025

Aspire Biopharma names new executive chair - MSN

Aug 18, 2025

Aug 15, 2025

Aspire Biopharma Successfully Launches BUZZ BOMB(TM) Pre-Workout Supplement at FitCon and FitExpo, Two of the Largest Fitness Conventions in the World - Lubbock Avalanche-Journal

Aug 15, 2025

Aug 14, 2025

Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference August 20 - Miami Herald

Aug 14, 2025

Aug 14, 2025

Aspire Biopharma to Present at Sidoti Virtual Investor Conference - AInvest

Aug 14, 2025

Aug 13, 2025

Aspire Biopharma’s BUZZ BOMB Shows Promising Initial Feedback - MSN

Aug 13, 2025

Aug 13, 2025

Aspire Biopharma Holdings, Inc. SEC 10-Q Report - TradingView

Aug 13, 2025

Aug 13, 2025

New Pre-Workout BUZZ BOMB Hits Market With Instant-Acting Sublingual Technology - Stock Titan

Aug 13, 2025

Aug 11, 2025

Aspire Biopharma Holdings, Inc. Announces CEO Transition - Lubbock Avalanche-Journal

Aug 11, 2025

Aug 11, 2025

Aspire Biopharma Holdings, Inc. Unveils E-commerce Platform, Launches with its BUZZ BOMB Pre-Workout Supplement - Petoskey News-Review

Aug 11, 2025

Aug 07, 2025

Riding the Waves: A Guide to Investing in ASBP Stock - investchronicle.com

Aug 07, 2025

Aug 06, 2025

Aspire Biopharma Holdings, Inc. shares rise 4.06% after-hours following Ultragenyx Pharmaceutical Inc. Q2 2025 earnings call. - AInvest

Aug 06, 2025

Jul 31, 2025

Aspire Biopharma Holdings, Inc. shares rise 2.10% after-hours after unveiling e-commerce platform and launching BUZZ BOMB supplement. - AInvest

Jul 31, 2025

Jul 31, 2025

What catalysts could drive Aspire Biopharma Holdings Inc. stock higher in 2025Expert Picks Tracker For Beginners - Jammu Links News

Jul 31, 2025

Jul 31, 2025

Game-Changing Pre-Workout Supplement Delivers Instant Energy Without Water MixingBUZZ BOMB Hits Market - Stock Titan

Jul 31, 2025

Jul 31, 2025

Why is Aspire Biopharma Holdings Inc. Equity Warrant stock attracting strong analyst attentionDaily Trading Insights With High Returns - Jammu Links News

Jul 31, 2025

Jul 31, 2025

Aspire Biopharma Announces Leadership Reshuffle Amid Resignations - msn.com

Jul 31, 2025

Jul 30, 2025

What makes Aspire Biopharma Holdings Inc. Equity Warrant stock price move sharplyPost Market Outlook For Smart Trading - Jammu Links News

Jul 30, 2025

Jul 30, 2025

Aspire Biopharma Leadership Shakeup: Chairman Takes CEO Role Amid Board Restructuring - Stock Titan

Jul 30, 2025

Jul 30, 2025

Aspire Biopharma CEO Out After Less Than Two Months, Two Directors Resign - 富途牛牛

Jul 30, 2025

Jul 30, 2025

ASBP CEO & Audit Chair Resign; Former CEO Returns as Interim | PWUPU SEC FilingForm 8-K - Stock Titan

Jul 30, 2025

Jul 30, 2025

Uncorrelated Capital Launches with $53M in Funding for Litigation Finance - The Arizona Republic

Jul 30, 2025

Jul 28, 2025

What catalysts could drive Aspire Biopharma Holdings Inc. Equity Warrant stock higher in 2025Capitalize on fast-moving stock trends - Jammu Links News

Jul 28, 2025

Jul 28, 2025

How many analysts rate Aspire Biopharma Holdings Inc. as a “Buy”Consistent triple returns - Jammu Links News

Jul 28, 2025

Jul 28, 2025

Why is Aspire Biopharma Holdings Inc. stock attracting strong analyst attentionSkyrocketing investment returns - Jammu Links News

Jul 28, 2025

Jul 28, 2025

What is the dividend policy of Aspire Biopharma Holdings Inc. stockConsistent triple-digit returns - Jammu Links News

Jul 28, 2025

Jul 28, 2025

How does Aspire Biopharma Holdings Inc. compare to its industry peersCapitalize on fast-growing stocks today - Jammu Links News

Jul 28, 2025

Jul 28, 2025

What is the risk reward ratio of investing in Aspire Biopharma Holdings Inc. stockUnlock powerful trading tools for investors - jammulinksnews.com

Jul 28, 2025

Jul 28, 2025

Is it the right time to buy Aspire Biopharma Holdings Inc. Equity Warrant stockCapitalize on emerging market trends - Jammu Links News

Jul 28, 2025